7th Annual Brasilian Symposium on Clinical & Pharmaceutical Solutions through Analysis (CPSA BRASIL 2020)
Roundtable Session Coordinator – CPSA Brazil 2020
Regina Oliveira, Ph.D. from Universidade Federal de São Carlos
“My passion is to know that I can make a difference.”
“[Make the general public] feel more comfortable knowing that it will pass, and that science will help them find the solution, to take away from health problem”
“Need to think about the disease (COVID-19) after recovery.”
In a response to a pandemic such as COVID-19, Regina looks to not only collect relevant data from patient samples – she also educates her family, friends, and community that we will get through this crisis together. Along with education with generating accurate knowledge, her lab (among many projects) works on diseases related to COVID-19 that appear months to years after the infection and recovery. The knowledge is created through clinical research with metabolomics – a technology that has been on the front line for COVID-19 patients that present other diseases post recovery. Although complex in nature, Regina creates understandable biological knowledge that is helping patients – and can be shared with the population as a whole.
Roundtable Session – Lead by Regina Oliveira, Ph.D
Gustavo Simões, CEO Nanox, São Carlos, São Paulo, Brazil
Markus Schreyer, CEO & Founder, Ganeshalab
Valdemir Carvalho, Ph,D, Senior Scientific Consultant at Fleury Group, São Paulo, Brazil
Roundtable Contributors
Gustavo Mendes Lima Santos
Carlos Kiffer, MD, Ph.D.
Marc Chalom